WILLIAM ULRICH: Open Payments
NPI 1942537923 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 41 payments from 13 companies in 2025. Trend: 2023 $433 · 2024 $541 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $184 |
| AstraZeneca Pharmaceuticals LP | 4 | $184 |
| Xeris Pharmaceuticals, Inc. | 3 | $55 |
| Axsome Therapeutics, Inc. | 5 | $48 |
| JAZZ PHARMACEUTICALS INC. | 1 | $26 |
| Novo Nordisk Inc | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| SHIELD THERAPEUTICS INC | 1 | $16 |
Products named: AIRSUPRA, VRAYLAR, QULIPTA, Auvelity, GVOKE HYPOPEN, XYWAV, UBRELVY, RECORLEV.
Industry payments across ID — which companies pay providers there.
